Successive treatment with cyclosporine and infliximab in steroid-refractory ulcerative colitis

Autor: Leblanc, S., Allez, M., Seksik, P., Flourié, B., Peeters, H., Dupas, J. L., Bouguen, G., Peyrin-Biroulet, L., Duclos, B., Bourreille, A., Dewit, O., Bouhnik, Y., Michetti, P., Chaussade, S., Saussure, P., Mary, J. Y., Colombel, J. F., Lémann, M., Renseigné, Non
Přispěvatelé: Université Pierre et Marie Curie - Paris 6 (UPMC), Institut de biologie et chimie des protéines [Lyon] (IBCP), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Zdroj: The American Journal of Gastroenterology
The American Journal of Gastroenterology, 2011, 106 ((4)), pp.771-7. ⟨10.1038/ajg.2011.62⟩
ISSN: 0002-9270
1572-0241
Popis: International audience; OBJECTIVES: Rescue therapy with either cyclosporine (CYS) or infliximab (IFX) is an effective option in patients with intravenous steroid-refractory attacks of ulcerative colitis (UC). In patients who fail, colectomy is usually recommended, but a second-line rescue therapy with IFX or CYS is an alternative. The aims of this study were to investigate the efficacy and tolerance of IFX and CYS as a second-line rescue therapy in steroid-refractory UC or indeterminate colitis (IC) unsuccessfully treated with CYS or IFX. METHODS: This was a retrospective survey of patients seen during the period 2000-2008 in the GETAID centers. Inclusion criteria included a delay of
Databáze: OpenAIRE